Profil
Henrik Sundin is the founder of Finserve Nordic AB, founded in 2006, holding the title of Partner.
Mr. Sundin is currently Director at Infra Group Nordic Consulting AB since 2019 and Director at Hamlet BioPharma AB since 2025.
Mr. Sundin was Chief Executive Officer at Movestic Fonder AB from 2010 to 2016.
Aktive Positionen von Henrik Sundin
| Unternehmen | Position | Beginn |
|---|---|---|
| HAMLET PHARMA AB (PUBL) | Direktor/Vorstandsmitglied | 04.12.2025 |
Finserve Nordic AB
Finserve Nordic AB Investment ManagersFinance Provides investment advice | Gründer | 01.11.2006 |
Infra Group Nordic Consulting AB
Infra Group Nordic Consulting AB Miscellaneous Commercial ServicesCommercial Services Provides infrastructure services | Direktor/Vorstandsmitglied | 01.12.2019 |
Ehemalige bekannte Positionen von Henrik Sundin
| Unternehmen | Position | Ende |
|---|---|---|
Movestic Kapitalförvaltning AB
Movestic Kapitalförvaltning AB Investment ManagersFinance Movestic Fonder employs active and passive strategies to manage their funds, aiming to achieve significant, stable returns by diversifying risk and continuously adapting their funds. Their geographic focus is on Nordic countries. The firm invests in equity and fixed income. They may also invest directly in certificates and may use derivatives for efficient portfolio management and/or hedging purposes. | Vorstandsvorsitzender | 01.08.2016 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Finserve Nordic AB
Finserve Nordic AB Investment ManagersFinance Provides investment advice | Finance |
Movestic Kapitalförvaltning AB
Movestic Kapitalförvaltning AB Investment ManagersFinance Movestic Fonder employs active and passive strategies to manage their funds, aiming to achieve significant, stable returns by diversifying risk and continuously adapting their funds. Their geographic focus is on Nordic countries. The firm invests in equity and fixed income. They may also invest directly in certificates and may use derivatives for efficient portfolio management and/or hedging purposes. | Finance |
Hamlet BioPharma AB
Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients | Health Technology |
Infra Group Nordic Consulting AB
Infra Group Nordic Consulting AB Miscellaneous Commercial ServicesCommercial Services Provides infrastructure services | Commercial Services |
















